Condition: Chronic Hepatitis B · Sponsor: Institute of Gastroenterology and Hepatology, Vietnam
Adherence to chronic Hepatitis B (HBV) treatment and regular follow-up visits is essential for preventing dangerous complications, yet adherence rates in Vietnam remain low due to barriers in patient awareness and geographic conditions. Digital health solutions, particularly mobile applications, have shown potential as tools for supporting patients in proactive disease management. The HBVCare mobile application was developed to provide features such as medication reminders, storage of lab results, and health education to improve treatment adherence and clinical outcomes. The investigators are conducting a multicenter, randomized controlled trial at Hoang Long Clinic and Hanoi Medical University Hospital to evaluate the effectiveness of HBVCare. Patients are randomized into either a control group receiving standard care and an intervention group using the HBVCare app, with patient adherence and related factors assessed after three months of treatment.
This description comes directly from the study's public registry record.
Trung Quoc Vu · +84796262002 · vuquoctrung0305@gmail.com
Hang Viet Dao, MD, PhD · +84987988075 · hangdao.fsh@gmail.com; daoviethang@hmu.edu.vn
Always discuss trial participation with your own doctor first.
| Hanoi Medical University Hospital | Hanoi, Vietnam | Recruiting |
| Institute of Gastroenterology and Hepatology | Hanoi, Vietnam | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07540637